Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
4
CHENGUANG MEDICAL
430300
5
TLC
873576
(FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.94%723.88M | 10.05%188.33M | 10.44%183.88M | 10.31%179.21M | 13.15%172.45M | 19.24%652.5M | 13.91%171.14M | 17.72%166.5M | 20.43%162.46M | 26.33%152.41M |
Operating revenue | 10.94%723.88M | 10.05%188.33M | 10.44%183.88M | 10.31%179.21M | 13.15%172.45M | 19.24%652.5M | 13.91%171.14M | 17.72%166.5M | 20.43%162.46M | 26.33%152.41M |
Cost of revenue | 19.63%77.19M | 12.72%19.6M | 23.33%19.8M | 23.13%19.99M | 19.92%17.8M | 14.08%64.52M | 14.38%17.39M | 5.89%16.05M | 18.00%16.23M | 19.37%14.85M |
Gross profit | 9.98%646.68M | 9.75%168.73M | 9.06%164.08M | 8.89%159.23M | 12.42%154.64M | 19.84%587.98M | 13.86%153.74M | 19.14%150.45M | 20.71%146.22M | 27.13%137.56M |
Operating expense | 6.46%913.42M | 4.79%232.32M | 4.86%224.26M | 7.48%236.02M | 8.88%220.81M | -4.51%857.98M | -5.36%221.69M | -5.94%213.87M | -5.51%219.61M | -0.80%202.81M |
Selling and administrative expenses | 7.25%571.95M | 6.75%148.08M | 6.12%140.98M | 7.13%144.87M | 9.11%138.02M | -11.31%533.29M | -9.32%138.72M | -12.53%132.84M | -13.96%135.24M | -9.15%126.49M |
-Selling and marketing expense | 7.14%419.95M | -1.60%102.26M | 6.47%104.71M | 12.65%108.65M | 11.90%104.33M | -9.89%391.96M | -9.42%103.92M | -13.51%98.35M | -12.63%96.45M | -3.00%93.24M |
-General and administrative expense | 7.55%152M | 31.68%45.82M | 5.15%36.27M | -6.61%36.22M | 1.31%33.69M | -15.02%141.33M | -9.02%34.8M | -9.62%34.49M | -17.10%38.79M | -22.86%33.26M |
Research and development costs | 5.17%341.47M | 1.53%84.24M | 2.79%83.29M | 8.04%91.15M | 8.48%82.79M | 9.25%324.69M | 2.11%82.97M | 7.31%81.03M | 12.15%84.37M | 17.04%76.32M |
Operating profit | 1.21%-266.74M | 6.42%-63.59M | 5.11%-60.18M | -4.65%-76.8M | -1.42%-66.17M | 33.80%-270M | 31.51%-67.95M | 37.27%-63.42M | 34.05%-73.38M | 32.20%-65.25M |
Net non-operating interest income expense | -5.88%16.17M | -23.21%3.39M | -23.48%3.88M | 21.86%4.45M | 10.16%4.43M | 190.63%17.18M | 9.73%4.42M | 180.91%5.08M | 1,422.92%3.66M | 2,539.39%4.03M |
Non-operating interest income | -6.05%19.85M | -21.73%4.25M | -20.86%4.82M | 17.00%5.41M | 7.69%5.38M | 167.10%21.13M | 10.65%5.43M | 168.90%6.09M | 739.02%4.62M | 2,500.00%4.99M |
Non-operating interest expense | -6.81%3.68M | -15.22%852K | -7.71%934K | -1.34%955K | -2.59%942K | 97.60%3.95M | 14.86%1.01M | 121.44%1.01M | 211.25%968K | 170.87%967K |
Other net income (expense) | 59.92%-202K | -135.36%-668K | 105.02%131K | 394.98%1.35M | -250.74%-1.02M | 48.41%-504K | -16.01%1.89M | -168.14%-2.61M | 35.94%-458K | 143.82%674K |
Gain on sale of security | 476.83%618K | -34.82%629K | 42.20%-893K | 597.17%1.41M | -175.11%-525K | -120.47%-164K | -31.22%965K | -632.23%-1.55M | -212.30%-283K | 208.71%699K |
Other non- operating income (expenses) | -141.18%-820K | -240.37%-1.3M | 196.24%1.02M | 68.00%-56K | -1,864.00%-491K | 80.88%-340K | 9.22%924K | -39.63%-1.06M | 81.90%-175K | 97.21%-25K |
Income before tax | 1.01%-250.77M | 1.26%-60.86M | 7.86%-56.17M | -1.15%-70.99M | -3.64%-62.75M | 37.12%-253.33M | 33.68%-61.64M | 39.21%-60.95M | 37.19%-70.19M | 38.18%-60.55M |
Income tax | 28.61%4.77M | 89.20%1.44M | 45.85%1.16M | -2.52%1.2M | 5.31%971K | -24.00%3.71M | -63.67%759K | 26.15%796K | 0.49%1.23M | -1.18%922K |
Net income | 0.58%-255.54M | 0.16%-62.3M | 7.16%-57.33M | -1.09%-72.19M | -3.67%-63.72M | 36.97%-257.03M | 34.34%-62.4M | 38.80%-61.75M | 36.78%-71.41M | 37.83%-61.47M |
Net income continuous Operations | 0.58%-255.54M | 0.16%-62.3M | 7.16%-57.33M | -1.09%-72.19M | -3.67%-63.72M | 36.97%-257.03M | 34.34%-62.4M | 38.80%-61.75M | 36.78%-71.41M | 37.83%-61.47M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 0.58%-255.54M | 0.16%-62.3M | 7.16%-57.33M | -1.09%-72.19M | -3.67%-63.72M | 36.97%-257.03M | 34.34%-62.4M | 38.80%-61.75M | 36.78%-71.41M | 37.83%-61.47M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 0.58%-255.54M | 0.16%-62.3M | 7.16%-57.33M | -1.09%-72.19M | -3.67%-63.72M | 36.97%-257.03M | 34.34%-62.4M | 38.80%-61.75M | 36.78%-71.41M | 37.83%-61.47M |
Basic earnings per share | 5.13%-1.11 | 3.57%-0.27 | 10.71%-0.25 | 6.06%-0.31 | 0.00%-0.28 | 42.65%-1.17 | 36.36%-0.28 | 42.86%-0.28 | 44.07%-0.33 | 46.15%-0.28 |
Diluted earnings per share | 5.13%-1.11 | 3.57%-0.27 | 10.71%-0.25 | 6.06%-0.31 | 0.00%-0.28 | 42.65%-1.17 | 36.36%-0.28 | 42.86%-0.28 | 44.07%-0.33 | 46.15%-0.28 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |